FIELD: medicine.
SUBSTANCE: the present innovation deals with a self-gluing matrix system that contains crystalline aminolevulinic acid. The latter is in ready-to-use form being resistant at storage at minimal decomposition.
EFFECT: higher efficiency of application.
12 cl, 9 dwg, 6 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSDERMAL THERAPEUTIC SYSTEM FOR 5-AMINOLEVULINIC ACID HYDROCHLORIDE | 2012 |
|
RU2607657C2 |
| ESTRADIOL-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEM | 1994 |
|
RU2140784C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING ELECTROHYDRODYNAMICALLY PRODUCED FIBERS, COMPOSITION HAVING IMPROVED RETENTION TIME AT SITE OF USE | 2016 |
|
RU2701513C2 |
| THERAPEUTICAL PLASTER WITH POLYSILOXANE MATRIX CONTAINING CAPSAICIN | 2003 |
|
RU2349315C9 |
| TRANSDERMAL PREPARATION OF THE PROLONGED EFFECT SHOWING ANTIOSTEOPOROTIC ACTIVITY | 1993 |
|
RU2119337C1 |
| METHOD FOR MANUFACTURE OF MEDICINE FOR TRANSDERMAL ADMINISTRATION | 1990 |
|
RU2044541C1 |
| TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AZENAPINE AND POLYSILOXANE OR POLYISOBUTYLENE | 2017 |
|
RU2764443C2 |
| COATED COMPOUND CONTAINING PHARMACEUTICAL AGENT | 2004 |
|
RU2372893C2 |
| TASTE IBUPROFEN MASKING WITH POLYMER COATING | 1991 |
|
RU2101010C1 |
| PATCH WITH MICRONEEDLES FOR DELIVERY OF ACTIVE INGREDIENT INTO THE SKIN | 2016 |
|
RU2803383C2 |
